Nanomedicine, Volume IIA: Biocompatibility

© 2003 Robert A. Freitas Jr. All Rights Reserved.

Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003


References 5000-5099

5000. M.J. During, A. Freese, B.A. Sabel, W.M. Saltzman, A. Deutch, R.H. Roth, R. Langer, “Controlled release of dopamine from a polymeric brain implant: in vivo characterization,” Ann. Neurol. 25(April 1989):351-356, 27(January 1990):109-110 (comment); A. Freese, B.A. Sabel, W.M. Saltzman, M.J. During, R. Langer, “Controlled release of dopamine from a polymeric brain implant: in vitro characterization,” Exp. Neurol. 103(March 1989):234-238.

5001. R.J. Tamargo, J.I. Epstein, C.S. Reinhard, M. Chasin, H. Brem, “Brain biocompatibility of a biodegradable, controlled-release polymer in rats,” J. Biomed. Mater. Res. 23(February 1989):253-266; H. Brem, A. Kader, J.I. Epstein, R.J. Tamargo, A. Domb, R. Langer, K.W. Leong, “Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain,” Sel. Cancer Ther. 5(1989):55-65.

5002. E.M. Powell, M.R. Sobarzo, W.M. Saltzman, “Controlled release of nerve growth factor from a polymeric implant,” Brain Res. 515(7 May 1990):309-311.

5003. D.F. Emerich, M.A. Tracy, K.L. Ward, M. Figueiredo, R. Qian, C. Henschel, R.T. Bartus, “Biocompatibility of poly (DL-lactide-co-glycolide) microspheres implanted into the brain,” Cell Transplant. 8(January-February 1999):47-58.

5004. S.R. Winn, P. Aebischer, P.M. Galletti, “Brain tissue reaction to permselective polymer capsules,” J. Biomed. Mater. Res. 23(January 1989):31-44.

5005. M. Dubach, M.E. Anderson, P.A. Tresco, “Extended local access fibers: adjustable treatment of deep sites in the brain,” J. Neurosci. Methods 85(1 December 1998):187-200.

5006. M. Itoh, S. Izumi, M. Uemura, N. Baba, K. Suyama, Y. Kuga, A. Mizuno, P.K. Nakane, T. Koji, “Prevention of death of axotomized hypoglossal neurones and promotion of regeneration by chitin grafting,” Cell Mol. Neurobiol. 20(October 2000):529-540.

5007. T.A. Barbolt, M. Odin, M. Leger, L. Kangas, J. Hoiste, S.H. Liu, T.A. Barbolt, M. Odin, M. Leger, L. Kangas, J. Hoiste, S.H. Liu, “Biocompatibility evaluation of dura mater substitutes in an animal model,” Neurol. Res. 23(December 2001):813-820.

5008. M.M. Mofid, R.C. Thompson, C.A. Pardo, P.N. Manson, C.A. Vander Kolk, “Biocompatibility of fixation materials in the brain,” Plast. Reconstr. Surg. 100(July 1997):14-20, 21-22 (discussion).

5009. N.L. Schenck, M.J. Tomlinson, “Frontal sinus trauma: experimental reconstruction with proplast,” Laryngoscope 87(March 1977):398-407.

5010. F. Gobeil, C. Juneau, S. Plante, “Thrombus formation on guide wires during routine PTCA procedures: a scanning electron microscopic evaluation,” Can. J. Cardiol. 18(March 2002):263-269.

5011. M. Montero, R. Mendez, M. Tellado, E. Pais, D. Vela, J. Candal, “A comparative study of the treatment of vesicoureteral reflux in childhood: a review of a series of 636 refluxing units,” Cir. Pediatr. 12(October 1999):144-147 (in Spanish); J. Lopez Lopez, J. Sanchez Zalabardo, M. Sanchez Elipe, J. Valdivia Uria, J. Valle Gerhold, A. Jimenez Vidal, “Endoscopic treatment of vesicoureteral reflux,” An. Esp. Pediatr. 54(February 2001):132-135 (in Spanish); C. Bertschy, D. Aubert, C. Piolat, C. Billerey, “Uretero-vesical implantation after failure of endoscopic treatment of reflux: anatomical and histological study of 61 resection specimens from 40 children,” Prog. Urol. 11(February 2001):113-117, 118(discussion) (in French); P. Chaffange, R. Dubois, A. Bouhafs, A.F. Valmalle, H. Dodat, “Endoscopic treatment of vesicorenal reflux in children: short- and long-term results of polytetrafluoroethylene (Teflon) injections,” Prog. Urol. 11(June 2001):546-551 (in French); N. Capozza, M. Patricolo, A. Lais, E. Matarazzo, P. Caione, “Endoscopic treatment of vesico-ureteral reflux: twelve years’ experience,” Urol. Int. 67(2001):228-231; D. Pelaez Mata, J.A. Alvarez Zapico, “Current aspects in the treatment of vesicoureteral reflux. Analysis of our experience,” Cir. Pediatr. 14(July 2001):112-115 (in Spanish).

5012. L. Kostopoulos, N. Lioubavina, T. Karring, R. Uraguchi, “Role of chitin beads in the formation of jaw bone by guided tissue regeneration. An experiment in the rat,” Clin. Oral. Implants Res. 12(August 2001):325-331.

5013. M. Roldan Pallares, S. Awad-El Susi, “Polytetrafluoroethylene in scleral buckling surgery,” Arch. Soc. Esp. Oftalmol. 75(September 2000):605-609. In Spanish.

5014. D.O. Mikaelian, L.D. Lowry, R.T. Sataloff, “Lipoinjection for unilateral vocal cord paralysis,” Laryngoscope 101(May 1991):465-468, 101(December 1991):1385 (comment); J.H. Brandenburg, W. Kirkham, D. Koschkee, “Vocal cord augmentation with autogenous fat,” Laryngoscope 102(May 1992):495-500; G.Y. Shaw, M.A. Szewczyk, J. Searle, J. Woodroof, “Autologous fat injection into the vocal folds: technical considerations and long-term follow-up,” Laryngoscope 107(February 1997):177-186; M.W. Hsiung, P. Woo, A. Minasian, J. Schaefer Mojica, “Fat augmentation for glottic insufficiency,” Laryngoscope 110(June 2000):1026-1033; L. Rovo, J. Czigner, A. Szamoskozi, M.A. Brzozka, “Endolaryngeal lipoaugmentation of the vocal cords,” Otolaryngol. Pol. 53(1999):709-713. In Polish.

5015. T. Chandy, G.S. Das, R.F. Wilson, G.H. Rao, “Use of plasma glow for surface-engineering biomolecules to enhance bloodcompatibility of Dacron and PTFE vascular prosthesis,” Biomaterials 21(April 2000):699-712.

5016. B.Y. Park, J.P. Hong, W.J. Lee, “Netting operation to control neurofibroma of the face,” Plast. Reconstr. Surg. 109(1 April 2002):1228-36, 1237 (discussion).

5017. M. Kamba, Y. Seta, A. Kusai, K. Nishimura, “Comparison of the mechanical destructive force in the small intestine of dog and human,” Int. J. Pharm. 237(26 April 2002):139-149; “Evaluation of the mechanical destructive force in the stomach of dog,” Int. J. Pharm. 228(9 October 2001):209-217; M. Kamba, Y. Seta, A. Kusai, M. Ikeda, K. Nishimura, “A unique dosage form to evaluate the mechanical destructive force in the gastrointestinal tract,” Int. J. Pharm. 208(4 November 2000):61-70.

5018. A.M. van Berkel, J. van Marle, H. van Veen, A.K. Groen, K. Huibregtse, “A scanning electron microscopic study of biliary stent materials,” Gastrointest. Endosc. 51(January 2000):19-22, 104-107 (comment); T. Gyokeres, A. Pap, “Use of two teflon stents in malignant non-hilar biliary atresia,” Orv. Hetil. 141(9 January 2000):77-82 (in Hungarian); M.F. Catalano et al, “‘Tannenbaum’ Teflon stents versus traditional polyethylene stents for treatment of malignant biliary stricture,” Gastrointest. Endosc. 55(March 2002):354-358.

5019. P.H. Dejonckere, H.A. van Wijngaarden, “Retropharyngeal autologous fat transplantation for congenital short palate: a nasometric assessment of functional results,” Ann. Otol. Rhinol. Laryngol. 110(February 2001):168-172; D.A. Klotz, J. Howard, A.S. Hengerer, O. Slupchynskj. “Lipoinjection augmentation of the soft palate for velopharyngeal stress incompetence,” Laryngoscope 111(December 2001):2157-2161.

5020. D. Alehan, R. Dogan, S. Ozkutlu, H. Elshershari, F. Gumruk, “Severe hemolytic anemia after repair of primum septal defect and cleft mitral valve,” Turk. J. Pediatr. 43(October-December 2001):329-331.

5021. J. Chen, S. Lee, T. Lui, Y. Yeh, T. Chen, W. Tzaan, “Teflon granuloma after microvascular decompression for trigeminal neuralgia,” Surg. Neurol. 53(March 2000):281-287; R.T. Sataloff, M.J. Hawkshaw, “Teflon granuloma,” Ear Nose Throat J. 79(June 2000):422; A. Khalil, G. Ghazeeri, M. Chammas, I. Usta, J. Awwad, M. Seoud, “Teflonoma presenting as a cystourethrocele,” Clin. Exp. Obstet. Gynecol. 28(2001):58-59; C.R. Billante, K.A. Burkard, J.M. Clary, P. Childs, J.L. Netterville, “Voice outcome following lateral laryngotomy to remove teflon granuloma,” ORL J. Otorhinolaryngol. Relat. Spec. 63(September-October 2001):302-306; T.A. Loehrl, T.L. Smith, “Inflammatory and granulomatous lesions of the larynx and pharynx,” Am. J. Med. 111(3 December 2001):113S-117S (Suppl 8A).

5022. S. Herschorn, “Current status of injectable agents for female stress urinary incontinence,” Can. J. Urol. 8(June 2001):1281-1289.

5023. M. Svartengren, K. Sommerer, G. Scheuch, M. Kohlhaeufl, J. Heyder, R. Falk, R. Bergmann, W. Hofmann, M. Bailey, K. Philipson, P. Camner, “Comparison of clearance of particles inhaled with bolus and extremely slow inhalation techniques,” Exp. Lung Res. 27(June 2001):367-386; K. Philipson, R. Falk, M. Svartengren, N. Jarvis, M. Bailey, R. Bergmann, W. Hofmann, P. Camner, “Does lung retention of inhaled particles depend on their geometric diameter?” Exp. Lung Res. 26(September 2000):437-455.

5024. A. Karadag, S. Gorgulu, “Effect of two different short peripheral catheter materials on phlebitis development,” J. Intraven. Nurs. 23(May-June 2000):158-166.

5025. P. Maier, “Development of hepatocyte cultures in toxicity testing,” ALTEX 6(1989):38-50.

5026. B. Granum, P.I. Gaarder, E. Groeng, R. Leikvold, E. Namork, M. Lovik, “Fine particles of widely different composition have an adjuvant effect on the production of allergen-specific antibodies,” Toxicol. Lett. 118(3 January 2001):171-181.

5027. M. Geiser, P. Gerber, I. Maye, V. Im Hof, P. Gehr, “Retention of Teflon particles in hamster lungs: a stereological study,” J. Aerosol Med. 13(Spring 2000):43-55.

5028. E. Neil, G. Marsh, “Towards the nonstick egg: designing fluorous proteins,” Chem. Biol. 7(July 2000):R153-R157.

5029. K.O. Viddal, G. Schistad, T. Nordshus, “Endoscopic treatment of vesicoureteral reflux in children,” Tidsskr. Nor. Laegeforen 120(10 February 2000):434-436, Ugeskr. Laeger 162(17 April 2000):2335-2337. In Norwegian.

5030. H. Cao, V. Verge, C. Baron, C. Martinache, A. Leon, S. Scholl, N.C. Gorin, J. Salamero, S. Assari, J. Bernard, M. Lopez, “In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy,” J. Hematother. Stem Cell Res. 9(April 2000):183-194, 127-128 (comment).

5031. E.M. Maynard, E. Fernandez, R.A. Normann, “A technique to prevent dural adhesions to chronically implanted microelectrode arrays,” J. Neurosci. Methods 97(15 April 2000):93-101.

5032. J. Stein, I. Eliachar, J. Myles, H. Munoz-Ramirez, M. Strome, “Histopathologic study of alternative substances for vocal fold medialization,” Ann. Otol. Rhinol. Laryngol. 109(February 2000):221-226.

5033. C. Granata, P. Buffa, E. Di Rovasenda, G. Mattioli, P.L. Scarsi, E. Podesta, P. Dodero, V. Jasonni, “Treatment of vesico-ureteric reflux in children with neuropathic bladder: a comparison of surgical and endoscopic correction,” J. Pediatr. Surg. 34(December 1999):1836-1838.

5034. N. Busch, F. Lammert, S. Matern, “Biliary secretory immunoglobulin A is a major constituent of the new group of cholesterol crystal-binding proteins,” Gastroenterology 115(July 1998):129-138; D. Izhaky, L. Addadi, “Stereoselective interactions of a specialized antibody with cholesterol and epicholesterol monolayers,” Chemistry 6(3 March 2000):869-874; M. Geva, D. Izhaky, D.E. Mickus, S.D. Rychnovsky, L. Addadi, “Stereoselective recognition of monolayers of cholesterol, ent-cholesterol, and epicholesterol by an antibody,” Chembiochem. 2(1 April 2001):265-271; F. Lammert, S. Sudfeld, N. Busch, S. Matern, “Cholesterol crystal binding of biliary immunoglobulin A: visualization by fluorescence light microscopy,” World J. Gastroenterol. 7(April 2001):198-202; M. Epple, P. Lanzer, “How much interdisciplinarity is required to understand vascular calcifications? Formulation of four basic principles of vascular calcification,” Z. Kardiol. 90(2001):2-5 (Suppl 3).

5035. L. Addadi, S. Weiner, M. Geva, “On how proteins interact with crystals and their effect on crystal formation,” Z. Kardiol. 90(2001):92-98 (Suppl 3).

5036. M. Gross, “Molecular recognition. Crystallographic antibodies,” Nature 373(12 January 1995):105-106.

5037. P. Hasselbacher, H.R. Schumacher, “Immunoglobulin in tophi and on the surface of monosodium urate crystals,” Arthritis Rheum. 21(April 1978):353-361; P. Hasselbacher, “Binding of IgG and complement protein by monosodium urate monohydrate and other crystals,” J. Lab. Clin. Med. 94(October 1979):532-541.

5038. F. Kozin, D.J. McCarty, “Molecular orientation of immunoglobulin G adsorbed to microcrystalline monosodium urate monohydrate,” J. Lab. Clin. Med. 95(January 1980):49-58.

5039. T. Bardin, P. Varghese Cherian, H.R. Schumacher, “Immunoglobulins on the surface of monosodium urate crystals: an immunoelectron microscopic study,” J. Rheumatol. 11(June 1984):339-341.

5040. Seung-Wuk Lee, Chuanbin Mao, Christien E. Flynn, Angela M. Belcher, “Ordering of quantum dots using genetically engineered viruses,” Science 296(3 May 2002):892-895; Comment at: C.K. Ober, “Self-assembly. Persistence pays off,” Science 296(3 May 2002):859-861.

5041. W.J. Parak, M. George, M. Kudera, H.E. Gaub, J.C. Behrends, “Effects of semiconductor substrate and glia-free culture on the development of voltage-dependent currents in rat striatal neurones,” Eur. Biophys. J. 29(2001):607-620.

5042. C. Ebner, K. Hoffmann-Sommergruber, H. Breiteneder, “Plant food allergens homologous to pathogenesis-related proteins,” Allergy 56(2001):43-44 (Suppl 67); K. Hoffmann-Sommergruber, “Plant allergens and pathogenesis-related proteins. What do they have in common?” Int. Arch. Allergy Immunol. 122(July 2000):155-166.

5043. Janet S. Rimmer, Constance H. Katelaris, eds., Proceedings XVII International Congress of Allergology and Clinical Immunology, Hogrefe and Huber Publ., 2000.

5044. Reto Crameri, “Molecular Allergology,” SIAF;

5045. W. Kozak, M.J. Kluger, J. Tesfaigzi, A. Kozak, K.P. Mayfield, M. Wachulec, K. Dokladny, “Molecular mechanisms of fever and endogenous antipyresis,” Ann. NY Acad. Sci. 917(2000):121-134; J.B. Tatro, “Endogenous antipyretics,” Clin. Infect. Dis. 31(October 2000):S190-S201 (Suppl 5).

5046. W. Kozak, M.J. Kluger, A. Kozak, M. Wachulec, K. Dokladny, “Role of cytochrome P-450 in endogenous antipyresis,” Am. J. Physiol. Regul. Integr. Comp. Physiol. 279(August 2000):R455-R460;

5047. Y. Shi, K.L. Rock, “Cell death releases endogenous adjuvants that selectively enhance immune surveillance of particulate antigens,” Eur. J. Immunol. 32(January 2002):155-162; Y. Shi, W. Zheng, K.L. Rock, “Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses,” Proc. Natl. Acad. Sci. (USA) 97(19 December 2000):14590-14595;

5048. E.D. Kuempel, C.L. Tran, R.J. Smith, A.J. Bailer, “A biomathematical model of particle clearance and retention in the lungs of coal miners. II. Evaluation of variability and uncertainty,” Regul. Toxicol. Pharmacol. 34(August 2001):88-101.

5049. A. Lejeune, M. Moorjani, C. Gicquaud, J. Lacroix, P. Poyet, R. Gaudreault, “Nanoerythrosome, a new derivative of erythrocyte ghost: preparation and antineoplastic potential as drug carrier for daunorubicin,” Anticancer Res. 14(May-June 1994):915-919; M. Moorjani, A. Lejeune, C. Gicquaud, J. Lacroix, P. Poyet, R.C. Gaudreault, “Nanoerythrosomes, a new derivative of erythrocyte ghost II: identification of the mechanism of action,” Anticancer Res. 16(September-October 1996):2831-2836; A. Lejeune, P. Poyet, R.C. Gaudreault, C. Gicquaud, “Nanoerythrosomes, a new derivative of erythrocyte ghost: III. Is phagocytosis involved in the mechanism of action?” Anticancer Res. 17(September-October 1997):3599-3603; J. Desilets, A. Lejeune, J. Mercer, C. Gicquaud, “Nanoerythrosomes, a new derivative of erythrocyte ghost: IV. Fate of reinjected nanoerythrosomes,” Anticancer Res. 21(May-June 2001):1741-1747.

5050. V.J. Tomazic-Jezic, K. Merritt, T.H. Umbreit, “Significance of the type and the size of biomaterial particles on phagocytosis and tissue distribution,” J. Biomed. Mater. Res. 55(15 June 2001):523-529.

5051. A. Moore, E. Marecos, A. Bogdanov Jr., R. Weissleder, “Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model,” Radiology 214(February 2000):568-574.

5052. D.D. Stuart, G.Y. Kao, T.M. Allen, “A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1,” Cancer Gene Ther. 7(March 2000):466-475.

5053. S.M. Moghimi, A.C. Hunter, J.C. Murray, “Long-circulating and target-specific nanoparticles: theory to practice,” Pharmacol. Rev. 53(June 2001):283-318.

5054. P. Calvo, B. Gouritin, H. Chacun, D. Desmaele, J. D’Angelo, J.P. Noel, D. Georgin, E. Fattal, J.P. Andreux, P. Couvreur, “Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery,” Pharm. Res. 18(August 2001):1157-1166.

5055. P. Calvo, B. Gouritin, I. Brigger, C. Lasmezas, J. Deslys, A. Williams, J.P. Andreux, D. Dormont, P. Couvreur, “PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases,” J. Neurosci. Methods 111(30 October 2001):151-155.

5056. Y.N. Konan, R. Gurny, E. Allemann, “State of the art in the delivery of photosensitizers for photodynamic therapy,” J. Photochem. Photobiol. B 66(March 2002):89-106.

5057. P. Calvo, B. Gouritin, H. Villarroya, F. Eclancher, C. Giannavola, C. Klein, J.P. Andreux, P. Couvreur, “Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat,” Eur. J. Neurosci. 15(April 2002):1317-1326.

5058. Y. Li, Y. Pei, X. Zhang, Z. Gu, Z. Zhou, W. Yuan, J. Zhou, J. Zhu, X. Gao, “PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats,” J. Control Release 71(2 April 2001):203-211.

5059. S.M. Moghimi, A.C. Hunter, “Capture of stealth nanoparticles by the body’s defences,” Crit. Rev. Ther. Drug Carrier Syst. 18(2001):527-550.

5060. H. Glaumann, B.F. Trump, “Lysosomal degradation of cell organelles. IV. Heterophagocytosis and acute inflammation in liver after intravenous injection of isolated liver-cell plasma membranes,” Exp. Mol. Pathol. 25(December 1976):371-389; H. Glaumann, L. Marzella, “Degradation of membrane components by Kupffer cell lysosomes,” Lab. Invest. 45(December 1981):479-490.

5061. H. Glaumann, “Phagocytosis and intralysosomal digestion of subcellular organelles by Kupffer cells of rat liver,” Adv. Exp. Med. Biol. 73(1976):247-255 (PT-A).

5062. G. Martin, R.B. Sewell, N.D. Yeomans, D.J. Morgan, R.A. Smallwood, “Hepatic Kupffer cell function: the efficiency of uptake and intracellular degradation of 14C-labelled mitochondria is reduced in aged rats,” Mech. Ageing Dev. 73(March 1994):157-168.

5063. M.K. Badman, R.A. Pryce, S.B. Charge, J.F. Morris, A. Clark, “Fibrillar islet amyloid polypeptide (amylin) is internalised by macrophages but resists proteolytic degradation,” Cell Tissue Res. 291(February 1998):285-294.

5064. P.J. Coopman, M.T. Do, E.W. Thompson, S.C. Mueller, “Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity,” Clin. Cancer Res. 4(February 1998):507-515.

5065. J.P. Vos, M.L. Giudici, L.M. van Golde, A. Preti, S. Marchesini, M. Lopes-Cardozo, “Cultured oligodendrocytes metabolize a fluorescent analogue of sulphatide; inhibition by monensin,” Biochim. Biophys. Acta 1126(26 June 1992):269-276.

5066. J. Hiraoka, Y. Hirao, “Fate of sperm tail components after incorporation into the hamster egg,” Gamete Res. 19(April 1988):369-380.

5067. S.E. Lind, C.J. Smith, “Actin is a noncompetitive plasmin inhibitor,” J. Biol. Chem. 266(15 March 1991):5273-5278.

5068. A.E. Aranega, A. Reina, C. Velez, L. Alvarez, C. Melguizo, A. Aranega, “Circulating alpha-actin in angina pectoris,” J. Mol. Cell Cardiol. 25(January 1993):15-22; A.E. Aranega, A. Reina, M.A. Muros, L. Alvarez, J. Prados, A. Aranega, “Circulating alpha-actin protein in acute myocardial infarction,” Int. J. Cardiol. 38(January 1993):49-55; J. Prados, C. Melguizo, A.E. Aranega, F. Escobar-Jimenez, V. Cobo, R. Gonzalez, A. Aranega, “Circulating alpha-actin in non-insulin-dependent diabetics with autonomic dysfunction,” Int. J. Cardiol. 51(September 1995):127-130.

5069. K.D. Harper, J.F. McLeod, M.A. Kowalski, J.G. Haddad, “Vitamin D binding protein sequesters monomeric actin in the circulation of the rat,” J. Clin. Invest. 79(May 1987):1365-1370; J. Clin. Invest. 80(July 1987):277 (erratum).

5070. P.J. Goldschmidt-Clermont, H. Van Baelen, R. Bouillon, T.E. Shook, M.H. Williams, A.E. Nel, R.M. Galbraith, “Role of group-specific component (vitamin D binding protein) in clearance of actin from the circulation in the rabbit,” J. Clin. Invest. 81(May 1988):1519-1527.

5071. S.E. Lind, D.B. Smith, P.A. Janmey, T.P. Stossel, “Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation,” J. Clin. Invest. 78(September 1986):736-742.

5072. D.B. Smith, P.A. Janmey, S.E. Lind, “Circulating actin-gelsolin complexes following oleic acid-induced lung injury,” Am. J. Pathol. 130(February 1988):261-267.

5073. F. Minonzio, A.M. Ongari, E. Venegoni, V. Carbonelli, L. Licciardello, F. Capsoni, “Immunomodulation of polymorphonuclear leukocytes by D53 Immucytal and its constitutive fractions,” Boll. Ist. Sieroter. Milan 68(1989):241-248.

5074. A. Fiocchi, B. Vignati, P. Cinquepalmi, E. Machado, L. Peano, R. Pulejo, G. Puleo, D. Lietti, D. Merazzi, G. Caramia et al, “Treatment using immucytal in children with recurrent respiratory infections: an Italian multicenter experience,” Pediatr. Med. Chir. 11(May-June 1989):285-291. In Italian.

5075. A. Fiocchi, R. Arancio, P. Cinquepalmi, M. Sala, G.V. Zuccotti, E. Riva, M. Giovannini, “Recurrent respiratory infections in childhood: experience with a bacterial extract plus bacterial ribosomes (Immucytal),” J. Int. Med. Res. 18(January-February 1990):50-60.

5076. B. Balbi, A. Aufiero, A. Pesci, S. Oddera, P. Zanon, G.A. Rossi, D. Olivieri, “Lower respiratory tract inflammation in chronic bronchitis. Evaluation by bronchoalveolar lavage and changes associated with treatment with Immucytal, a biological response modifier,” Chest 106(September 1994):819-826.

5077. R. Mora, M. Barbieri, G.C. Passali, A. Sovatzis, F. Mora, M.P. Cordone, “A preventive measure for otitis media in children with upper respiratory tract infections,” Int. J. Pediatr. Otorhinolaryngol. 63(25 April 2002):111-118.

5078. T. Yajima, G.G. Rose, “Phagocytosis of collagen by human gingival fibroblasts in vitro,” J. Dent. Res. 56(October 1977):1271-1277.

5079. E.L. Svoboda, D.M. Brunette, A.H. Melcher, “In vitro phagocytosis of exogenous collagen by fibroblasts from the periodontal ligament: an electron microscopic study,” J. Anat. 128(March 1979):301-314.

5080. A. Yamasaki, G.G. Rose, C.J. Mahan, “Collagen degradation by human gingival fibroblasts. I. In vivo phagocytosis,” J. Periodontal Res. 16(May 1981):309-322.

5081. A.H. Melcher, J. Chan, “Phagocytosis and digestion of collagen by gingival fibroblasts in vivo: a study of serial sections,” J. Ultrastruct. Res. 77(October 1981):1-36.

5082. G.C. Knowles, M. McKeown, J. Sodek, C.A. McCulloch, “Mechanism of collagen phagocytosis by human gingival fibroblasts: importance of collagen structure in cell recognition and internalization,” J. Cell Sci. 98(April 1991):551-558.

5083. M.T. van der Pauw, T. Van den Bos, V. Everts, W. Beertsen, “Phagocytosis of fibronectin and collagens type I, III, and V by human gingival and periodontal ligament fibroblasts in vitro,” J. Periodontol. 72(October 2001):1340-1347.

5084. M. Ishii, Y. Terao, Y. Asai, T. Hamada, “High melanosome engulfing activity of cutaneous fibroblasts in macular amyloidosis: an electron microscopic study,” J. Cutan. Pathol. 11(December 1984):476-484.

5085. S.H. Elder, S.A. Goldstein, J.H. Kimura, L.J. Soslowsky, D.M. Spengler, “Chondrocyte differentiation is modulated by frequency and duration of cyclic compressive loading,” Ann. Biomed. Eng. 29(June 2001):476-482.

5086. J. Archambault, M. Tsuzaki, W. Herzog, A.J. Banes, “Stretch and interleukin-1beta induce matrix metalloproteinases in rabbit tendon cells in vitro,” J. Orthop. Res. 20(January 2002):36-39.

5087. N. Endlich, K.R. Kress, J. Reiser, D. Uttenweiler, W. Kriz, P. Mundel, K. Endlich, “Podocytes respond to mechanical stress in vitro,” J. Am. Soc. Nephrol. 12(March 2001):413-422.

5088. H.L. Jessop, M. Sjoberg, M.Z. Cheng, G. Zaman, C.P. Wheeler-Jones, L.E. Lanyon, “Mechanical strain and estrogen activate estrogen receptor alpha in bone cells,” J. Bone Miner. Res. 16(June 2001):1045-1055.

5089. H. Sakamoto, M. Aikawa, C.C. Hill, D. Weiss, W.R. Taylor, P. Libby, R.T. Lee, “Biomechanical strain induces class a scavenger receptor expression in human monocyte/macrophages and THP-1 cells: a potential mechanism of increased atherosclerosis in hypertension,” Circulation 104(3 July 2001):109-114.

5090. D.R. Pimentel, J.K. Amin, L. Xiao, T. Miller, J. Viereck, J. Oliver-Krasinski, R. Baliga, J. Wang, D.A. Siwik, K. Singh, P. Pagano, W.S. Colucci, D.B. Sawyer, “Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes,” Circ. Res. 89(31 August 2001):453-460.

5091. K.T. Nguyen, S.R. Frye, S.G. Eskin, C. Patterson, M.S. Runge, L.V. McIntire, “Cyclic strain increases protease-activated receptor-1 expression in vascular smooth muscle cells,” Hypertension 38(November 2001):1038-1043.

5092. R. Ohki, K. Yamamoto, H. Mano, R.T. Lee, U. Ikeda, K. Shimada, “Identification of mechanically induced genes in human monocytic cells by DNA microarrays,” J. Hypertens. 20(April 2002):685-691.

5093. M.Z. Cheng, S.C. Rawlinson, A.A. Pitsillides, G. Zaman, S. Mohan, D.J. Baylink, L.E. Lanyon, “Human osteoblasts’ proliferative responses to strain and 17beta-estradiol are mediated by the estrogen receptor and the receptor for insulin-like growth factor I,” J. Bone Miner. Res. 17(April 2002):593-602.

5094. Y.F. Hsieh, C.H. Turner, “Effects of loading frequency on mechanically induced bone formation,” J. Bone Miner. Res. 16(May 2001):918-924.

5095. C.E. Miller, K.J. Donlon, L. Toia, C.L. Wong, P.R. Chess, “Cyclic strain induces proliferation of cultured embryonic heart cells,” In Vitro Cell Dev. Biol. Anim. 36(November-December 2000):633-639.

5096. Marc L. Mansfield, Jack F. Douglas, Edward J. Garboczi, “Intrinsic viscosity and the electrical polarizability of arbitrarily shaped objects,” Phys. Rev. E 64(December 2001):61401-61416.

5097. M.S. Shchepinov, K.U. Mir, J.K. Elder, M.D. Frank-Kamenetskii, E.M. Southern, “Oligonucleotide dendrimers: stable nano-structures,” Nucleic Acids Res. 27(1 August 1999):3035-3041,; T.W. Nilsen, J. Grayzel, W. Prensky, “Dendritic nucleic acid structures,” J. Theor. Biol. 187(21 July 1997):273-284.

5098. S.C. Zimmerman, F. Zeng, D.E. Reichert, S.V. Kolotuchin, “Self-assembling dendrimers,” Science 271(23 February 1996):1095-1098, 1077-1078 (comment).

5099. Y. Kim, S.C. Zimmerman, “Applications of dendrimers in bio-organic chemistry,” Curr. Opin. Chem. Biol. 2(December 1998):733-742.


Last updated on 16 April 2004